Pharma & BiotechGSK Bets Big on Ultra-Long-Acting Biologics With 2027 Depemokimab Launch TargetFeb 18, 2026
Corporate StrategyGM Bets on 2028 Autonomous Driving Launch as R&D Spending Reshapes Detroit's Competitive LandscapeFeb 18, 2026
Mining & ResourcesArtemis Gold's Blackwater Mine EP2 Expansion: A $1.44 Billion Bet on Self-Funded GrowthFeb 18, 2026
Insurance & Corporate RestructuringAegon to Redomicile as Transamerica Inc. by 2028 in Major Strategic Pivot to USFeb 18, 2026
Corporate FinanceHo Chi Minh City's 2030 Electric Ride-Hailing Mandate Opens Billion-Dollar Infrastructure RaceFeb 18, 2026
Manufacturing & OperationsFord Pivots Ohio Plant to Gas and Hybrid Vans as EV Demand Fails to Justify InvestmentFeb 18, 2026
Corporate M&ABig Pharma Bets Big on Oncology: M&A Wave and Regulatory Wins Reshape Cancer Drug MarketFeb 17, 2026
Corporate StrategyBroadcom's $21 Billion AI Pivot: How Custom Silicon for Hyperscalers Is Reshaping the Chip GiantFeb 16, 2026
AnalysisMicrosoft's Enterprise AI Surge Exposes Infrastructure Bottlenecks as Competitors Rush to AdaptFeb 15, 2026
AnalysisFour Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near MarketFeb 15, 2026
AnalysisFour Major Drug Trials Hit Key Milestones in Early 2026, Signaling Productive Clinical Research CycleFeb 15, 2026
AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsFeb 15, 2026
AnalysisBroadcom Emerges as Critical AI Infrastructure Provider With $21B in Custom Chip OrdersFeb 15, 2026
Healthcare InvestmentPrecision Oncology Sector Reaches Inflection Point as Seven Companies Advance Toward FDA SubmissionsFeb 15, 2026
Finance IndustryFord Shifts Tennessee Plant to Gas Trucks, Reversing Electric Vehicle PlansFeb 15, 2026
Finance IndustryDPM Metals' Serbian Gold Project Shows $782M Valuation With Industry-Leading ReturnsFeb 15, 2026
